A sample report on
Indian Dermatological
Therapeutics Market
Analysis
Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com
This report presents a strategic analysis of the Indian Dermatology Therapeutics market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Indian Dermatology Therapeutics market, and offers unmatched value, accuracy, and expert insights
• Market Overview
• Growth Drivers & Restraints
• Major Dermatology Disease
Table of
• Market Segmentation
• Major Market Share
Contents
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Conclusion
Table of Contents
1. Indian Dermatology Therapeutics Market Overview…………………………………………..…………………………………....…...........7
1.1 Background
1.2 Introduction
1.3 Market size and forecast
2. Market Growth Drivers and Restraints …………………………………………………………………….…………………………………….11
2.1 Market Growth Drivers
2.1.1 Increase in incidence of skin diseases 2.1.2 Awareness regarding skin diseases
2.1.3 Rising number of working women
2.1.4 Demand for topical dermatology drugs 2.1.5 Easy accessibility of the products
2.1.6 Government Initiatives
2.2 Market Restraints
2.2.1 Serious side effects of drugs
2.2.2 Competitors in Market
4
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Table of Contents (continued)
3. Major Types of Dermatology Diseases…..…………………………………………………………………………………..………………..20
3.1 Eczema
3.2 Tinea Pedis
3.3 Urticaria/Angioedema
3.4 Atopic Dermatitis
3.5 Acne
4. Dermatology Market Segmentation………………………..…………………………………………………………………..……….….….23
4.1 By Disease Type
4.2 By Drug Class
4.3 By Route of Administration
4.4 By End Users
4.5 By Distribution Channel
5. Dermatology Major Products Market Share…………………………………………………………...…………..….......…………….….31
5.1 Market Analysis, Insights and Forecast - By Revenue 5
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Table of Contents (continued)
6. Competitive Landscape……………………………………………………………………………………………………………….……………....33
6.1 Major Players
6.2 Products in Pipeline
7.1 Sun Pharma
7.2 GlaxoSmithKline
7.3 Glenmark Pharmaceuticals
7.4 Galderma
7.5 USV Private Limited
8. Healthcare Policies and Regulatory Landscape………………………………….………………………………………………...……………..42
8.1 Regulatory Framework of Indian Dermatology Therapeutics Market
9. Factors Driving Future Growth………………………………………………………………………………………………………………….…...45
9.1 Future Opportunities
10. Conclusion………………………. …………………………………………………………………………………………………….………….…...47
10.1 Strategic Recommendations
6
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 1. Overview
1.1 Background
▪
Skin diseases are responsible for significant morbidity worldwide, but they do not get due importance in national health planning and policies in several countries. Although mortality due to skin diseases is low, they contribute to significant disability, and the non-fatal burden of skin and subcutaneous diseases is more than that of cardiovascular diseases in India
▪
In India, there were 4.07 million (95% uncertainty interval 2.65–6.19 million) years lived with disability due to skin and subcutaneous diseases in 1990, which increased to 6.26 million (95% uncertainty interval 4.12-9.35 million) in 2017. Although the number of years lived with disability has increased by 53.7% between 1990 and 2017, the increase in age-standardised years lived with disability rates was only 1.52%
▪
The high burden of skin and subcutaneous diseases demand that they be given due importance in the national programmes and health policy of India
8
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
1.2 Introduction
▪
As people age, the risk of developing skin-related disorders increases, due to factors, such as changes in the connective tissue, reduction in the skin’s strength and elasticity, and reduction in secretions from sebaceous glands
▪
Skin conditions pose a significant threat to patient’s well-being, mental health, ability to function, and social participation
▪
In India, Dermatitis (atopic, seborrheic and contact) contributed maximum to years lived with disability (1.40Mn, 95% uncertainty interval:0.82–2.21) followed by urticaria (1.02Mn, 95% uncertainty interval 0.06-1.44) with percentage increases of 48.9% and 45.7%, respectively
▪
Infections and infestations contributed to nearly 30 % of the total years lived with disability due to skin and subcutaneous diseases (fungal skin diseases- 12.6%, viral skin diseases-10.0% and scabies- 10.3%) 9
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
1.3 Market Size & Forecast
Indian Dermatology Therapeutics Market Size US$ Mn Key Analysis
▪
Indian Dermatology Therapeutics market size stood at XX
around US$ xx Bn in 2021 and is projected to reach US$
xx Bn by 2030, exhibiting a CAGR of around xx% during the forecast period
▪
The derma market has grown by approximately 4.5% per year on an average (CAGR). The current market size of the Dermatology segments in India is approximately $xx xx
Mn, growing rapidly at about xx%. In terms of revenue, the face care products was dominating the market with 57.22% share in 2020
▪
The increasing incidence of Dermatology diseases and increasing levels of awareness-related disease progression, etiology, and available therapies are leading 2021
2022F
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
to a high growth of Dermatology therapeutics in India 10
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 2. Growth Drivers & Restraints
2.1 Market Growth Drivers
Rise in the
incidence of skin
Demand for Topical
diseases
Dermatology drugs
Awareness
Easy
Market
regarding Skin
Accessibility of
Drivers
Diseases
the products
Rising number
Government
of working
Initiatives
women
12
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Market Growth Drivers
2.1.1 Rise in the incidence of skin diseases
•
With the rise in the aging population, Dermatology care is likely to receive particular attention
Sample
•
As people age, the risk of developing skin- related disorders increases due to factors, such as changes in the connective tissue, reduction in the skin's strength and elasticity, and reduction in secretions from sebaceous glands
13
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Market Growth Drivers (continued)
2.1.2 Awareness regarding skin diseases
▪
Increase in improvement of awareness regarding skin health in India
Sample
Sample
14
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Market Growth Drivers (continued)
2.1.3 Rising number of working women
▪
Rising number of working women and is leading to higher demand for personal care product
Sample
Sample
Sample
15
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Market Growth Drivers (continued)
2.1.4 Demand for Topical Dermatology drugs
•
Demand for topical Dermatology drugs has increased due to increased population. It directly affects the growth of Dermatology Market
•
Drugs such as anti-inflammatory agents, anti-infective, local Sample
anaesthetics, cleansers, and emollients to treat acne Sample
16
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Market Growth Drivers (continued)
2.1.5 Easy accessibility of the products
•
Easy accessibility of the products through company websites and online channels, and doorstep delivery are driving the market
Sample
Sample
Sample
17
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Market Growth Drivers (continued)
2.1.6 Government Initiatives
▪
The initiatives taken by the government are expected to contribute to the growth of the dermatology market in India
▪
For example, PMJY, is funded tertiary health coverage scheme, which provides cashless surgical treatments for Sample
various ailments, including Dermatology problems Sample
18
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
2.2 Market Restraints
2.2.1 Serious side effects
2.2.2 Competitors in market
▪
Due to the presence of numerous globally
▪
Serious side effects of certain classes of operating companies, the Indian skincare derma therapeutic drugs are expected to restrain the cosmetics market is fragmented, which is
market growth in the near future
prompting the players to launch new products Sample
Sample
19
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 3. Major Dermatology Diseases
3. Major Dermatology Diseases
3.1
3.2
3.3
Eczema
Tinea Pedis
Urticaria ⁄Angioedema
Chronic urticaria is a relatively common
In India, at least one in five
About 10% of the total
condition in India and most cases have no children suffer from eczema,
population may be affected by
specific allergic trigger and remain
also known as atopic
dermatophyte infections of the
idiopathic
dermatitis. “Since the
toe clefts
underlying causes are
incompletely known, we
The condition is more common
Autoimmune causes have been found to
undertook a study to identify
in adult males than in females
be associated with up to 30- 40% cases
correlates of the disease”
It is important to look for physical
urticarias such as pressure urticaria in
chronic cases
21
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Major Dermatology Diseases
3.4
3.5
Atopic Dermatitis
Acne
Atopic Dermatitis (AD) is hereditary and
In India, about 12 percent between 20 to 29
the most common type of eczema. AD
years of age had acne problems.
almost always starts in infancy or before Excess oil production, pores becoming
age 5
clogged by sticky skin cells, bacteria and inflammation directly contributed to acne problems
22
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 4. Market Segmentation
Snapshot of Dermatology Therapeutics Market Segmentation By Disease Type
By Drug Class
Dermatology
Market
By Route Of Administration
Segmentation
By End Users
By Distribution Type
24
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Snapshot of Dermatology Therapeutics Market Segmentation ROUTE OF
DISEASE TYPE
DRUG CLASS
ADMINISTRATION
END USERS
DISTRIBUTION CHANNEL
• Acne
• Anti-infectives
• Oral
• Home Care
• Pharmacy
• Dermatitis
• Corticosteroid
• Topical
• Hospital
Store
• Psoriasis
s
• Parenteral
• Dermatolog
• Retail Store
• Skin
• Calcineurin
Administratio
y
• Online
Cancer
inhibitors
n
Clinics
• Alopecia
• Retinoids
• Rosacea
• Antirheumatic
25
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
4.1 Market Segmentation: By Disease Type Indian Dermatology Therapeutic Market Share by Disease type Key Insights
2022
▪
Approximately 80 percent of Indian are affected by acne between the onset of puberty and 30 years of age. By the end of 2026, the number of people affected by acne in India is estimated to reach 23 million at a compound annual growth rate (compound average growth rate) of 0.5 percent.
▪
In India, the incidence of melanoma of the skin in the SAMPLE
North region is 1.62 for males and 1.21 for females for every 1,00,000 people. The overall incidence of nonmelanoma skin cancer is the highest in the Northeast region, going as high as 5.14 for men and 3.98 for women for every 1,00,000 people.
▪ Content
Acn
Eczem
Atopic
Skin
Tinea
e
a
Dermatiti
Cancer
Pedis
s
26
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
4.2 Market Segmentation: By Drug Type
Indian Dermatology Therapeutics Market Share by Drug Type Key Insights
2022
▪
The biologics segment is expanding at a large scale during the forecast period owing to the increasing regulatory approval of biologics.
▪
Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.
SAMPLE
▪
Topical corticosteroids are effective in a number of dermatoses. Dermatotherapy has always been a combination of art and science.
Anti-infectives Corticosteroids
Calceneurin
Retinoids
Antirhematic
Sample
Inhibitors
27
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
4.3 Market Segmentation: Route of Administration Indian Dermatology Therapeutic Market Share by Route of Key Insights
Administration, 2022
▪
In Indian dermatology therapeutics market, the topical segment held a large share of the market owing to the Parenteral
rise in the demand for topical Dermatology drugs such as administration
anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne.
Oral
SAMPLE
Topical
Topical
Oral
Parenteral
administration
28
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
4.4 Market Segmentation: By End Users
Indian Dermatology Therapeutic Market Share by End User, Key Insights
2022
▪
Hospitals provide medical, diagnostic, and treatment services to inpatients and some outpatient dermatology services, which is holding largest share of the dermatology market
▪
Large number patients are being treated at home, which SAMPLE
is holding market share following hospitals in dermatology market
Hospitals
Homecare
Dermatology Clinics
29
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
4.5 Market Segmentation: By Distribution Channels Indian Dermatology Therapeutic Market Share by Distribution Key Insights
Channel, 2022
▪
It is expected that the pharmacy and retail store category will lead throughout the forecast period.
▪
This is due to the availability of a broad range of over-the-counter derma products, which are available in the pharmacy and retail stores.
SAMPLE
▪
However, with the increasing trend toward online shopping and due to Covid-19 impact, people are preferring to make an online purchase and due to this online category is also witnessing faster growth in the dermatology market Pharmacy Store
Retail Store
Online
30
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 5. Major Product Market Share
5.1 Major Dermatology Products Market Share Indian Dermatology Therapeutics Major
Key Insights
Products Market Share
SAMPLE
Top Brands in Dermatology Therapeutics Market Brand 1
Brand 2
Brand3
Brand 4
44
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 6. Competitive Landscape
6.1 Major Players Revenue (Current and Forecast) Revenue of Major Dermatology Market Players ($Bn) 2021
2022F
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
Sun Pharma
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
GlaxoSmithKline
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
Glenmark
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
Pharmaceuticals
Galderma India Private
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
Limited
USV Private Limited.
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
$XX
34
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
6.2 Products in Pipeline
▪
Lipidor AB has penned an agreement with Cadila Pharmaceuticals to conduct a Phase III study for Lipidor’s drug candidate AKP-02.
AKP-02 is an antipsoriasis medicine that combines the active substances calcipotriol and betamethasone with Lipidor’s spray-based AKVANO technology
Content
Sample
48
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 7. Key Company Profiles
7.1 Sun Pharma
Company Profile
Company Name: Sun Pharma
Year of Establishment: 1983
Headquarter: India
Revenue: $4.5 Bn
Website www.sunpharma.com
Sample
37
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
7.2 GlaxoSmithKline
Company Profile
Company Name: GlaxoSmithKline
Year of Establishment: 2000
Headquarter: United Kingdom
Revenue: $xx Bn
Website: www.gsk.com
Sample
38
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
7.3 Glenmark Pharmaceuticals
Company Profile
Company Name: Glenmark Pharmaceuticals Year of Establishment: 1977
Headquarter: Mumbai, India
Revenue: $xx Bn
Website: www.glenmarkpharma.com
Sample
39
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
7.4 Galderma India Private Limited
Company Profile
Company Name: Galderma India Private Limited
Year of Establishment: 1981
Headquarter: SA Lausanne, Switzerland Revenue: $3.4 Bn
Website:
Sample
40
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
7.5 USV Private Limited
Company Profile
Company Name: USV Private
Limited
Year of Establishment: 1959
Headquarter: Mumbai, India
Revenue: $2.3 Bn
Website: www.usvindia.com
Sample
41
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 8. Healthcare Policy and Regulatory Landscape
8.1 Regulatory Framework of India Dermatology Therapeutics Market The Indian Association of Dermatologists, The journey that culminated in the
Venereologists and Leprologists (IADVL),
formation of IADVL as we know it today
the largest representing official society of took its first flight in 1947 when Dr. UB
Indian Dermatologists was established in its Narayan Rao, conceived the idea to create present form on 28th January, 1973
an association of Dermatologists and
Venereologists
IADVL is the national association of Indian A framework regarding rules was approved on medical specialists who manage patients
July 26, 1948 and the association started its with skin disorders, sexually transmitted work on establishing local branches in other infections (STIs) or leprosy. The association states. IADVL also happens to be the world’s works for the betterment of the specialty by 2nd largest Association of Dermatologists holding academic meetings, printing a
behind the American Academy of Dermatology journal (print version & online)
43
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Regulatory Framework of India Dermatology Therapeutic Market
•
The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) organization is ever committed to serving the public in the domains of dermatology. In lieu of this, IADVL observes several days of clinical significance including Leprosy day, Vitiligo day, World Skin Health Day to name a few
•
IADVL has a wing dedicated to Community outreach programs which not only help in taking quality skin care to the rural remote areas but also promote awareness on skin hygiene, equipping the local medical personnel to manage the common skin conditions and to refer the complicated cases to higher referral centers
•
Indian Dermatology Online Journal (IDOJ) is a bimonthly open access print journal of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) 44
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 9. Factors Driving Future Growth
9. Future Opportunities
The new vendors within the Dermatology
Diagnostic Devices and Therapeutics market face powerful competition from established international vendors as they struggle with technological innovations, dependability, and quality problems
.
The Indian Journal of Dermatology
The prime strategically activities
has always played a progressive
within the market are initiated by
role of acting as a medium for the
the key players which incorporate
ever- changing developments of
product developments, mergers,
scientific research in dermatology in
and acquisitions, partnerships, etc.
this part of the world
Future
Opportunities
46
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Indian Dermatology Therapeutics Market Analysis 10. Conclusion
10.1 Strategic Recommendations
Dermatology in the new
The importance of skin to the
Dermatologists may
millennium must focus on the
individual will not diminish,
themselves opt out of treating
needs, hopes, and
and funding agencies should
conditions which governance
satisfaction of those who
recognize this. The costs of
deems important. An example
consider themselves to have
treating skin diseases will
would be all breaks in surface
skin liaments. Governments
always be an issue, and the
continuity of the skin which
can change this by declaring
case for treating skin
other professions might wish
some unidentified needs to be
diseases will have to be
to take over as leg ulcers, the
important and thus fundable,
made in a competitive world
diabetic foot ulcer, the
while others are deemed
filled with many life-
pressure sore, or burns
unimportant
threatening diseases
48
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Methodology & Scope
Research Methodology
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
The currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages: Market Data Analysis &
Interpretation and
Data Collection
Statistical Model
Presentation
Analysis &
Market Trends
Interpretation
Secondary
Data
Market Sizing
Insights
& Analysis
Primary
Interviews
Data Triangulation
Presentation
& Validation
& Reporting
51
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Data Triangulation and Data Validation Top Down Approach
Final
Market
Final Market size break up to
Size
rest of segmentation
Validation from
Arriving at market size
Primary
of each segment
Interview
Summarization of revenue
generated from companies
Validation from
to arrive at total market size
Primary
Interview
Revenue generated by products &
Final
services offered by companies
Bottom
Su -up
mm A
ar nal
y
ysis
Bottom Up Approach
52
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Key Benefit for Stakeholders from this report The study provides an in-depth analysis of the Indian dermatology therapeutics market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 53
A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Base Year for
2021
Estimation
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities Report Customization (5 working days) with purchase. We will provide you with data that is Customized Report
currently not a part of our scope as a part of 2022-Forecast
customization
2030
Period
Pricing and purchase
Avail customized purchase options to meet options
your exact research needs
What kind of Data is Presented
in this Report?
This report presents data, which is:
Reliable
Expert-verified
Real
Comprehensive
Easy to read
The report is prepared
The data is prepared by
Allowing you to
Covers everything you
You do not have to be a
using a proven
a team of highly qualified
confidently make
would need to know
market expert to
methodology and
& experienced research
smarter business
about the market
understand what really is
insightful research
analysts & vetted by our
and strategic
including market size,
happening on the market
local associates
decisions
competitive analysis &
and how it works
much more
www.insights10.com
About
Lifesciences Market
Research Reports you
can trust
A large database of over 30,000 syndicated market research reports in pharmaceuticals and
healthcare sector at global, regional as well as country level. We also provide customized research reports tailor made to suit your needs
Get Insights to take
informed Business
Decisions
Insights10 is a healthcare focused market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for
businesses
Market Research Reports
across various domains of healthcare
Pharmaceuticals
Digital
Medical
Healthcare
OTC &
Clinical
(Diseases & Drugs) Health
Devices
Services
Nutraceuticals
Trials
Market Research Reports
1
6
Full-Time Engagement
Customized Reports
2
7
Conference Coverage
Our
Primary Research
3
Services
8
Competitive Intelligence
Strategic Research Projects
4
9
Regulatory Compliance
Database Services
5
10
Report Subscription Services
Our Research Process
01
02
03
04
05
Identification of
Market
Collection of
Collaboration
Verification &
Data
Dynamics
Data
of Data
Analysis
Statistical Databases
Company Websites/Annual Reports
Data
Sources
Trade Publications
We have access to multiple highly
Online Databases
reliable free and subscription data
sources. We have many years of
experience to understand which
Published Research Reports
sources are more dependable for what
and which to prefer for the reliable and
Whitepapers
latest information.
Press Releases of Key Market Players
Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
Research Projects Done
Project Leadership Team
Dr. Purav Gandhi
Mukesh Nayak
Ritu Baliya
Dhruv Joshi
Founder & CEO
Head - Marketing
Engagement Manager
Consultant
Purav is a physician and an
Mukesh is an engineering graduate
Ritu has over 6 years of experience in
Dhruv Joshi is an engineer and has done
entrepreneur with 12+ years of
with an MBA in Marketing. He is a
strategy building, market assessments,
Masters in Hospital Administration with
experience in Healthcare & Life
seasoned healthcare market
market sizing, and RWE for global MNC
over 4 years of experience in the
Sciences industry spanning across
research & marketing professional
healthcare & biopharma clients across healthcare and life science industry. He
strategy, market access, health
with a progressive experience of over
diff. markets (America, Europe, Africa,
has gained proficiency in market
informatics and RWE, digital health,
20 years in Life Sciences, Pharma
APAC and Middle East). Her areas of
research, market assessment, and
analytics and data science. Purav
and Medical Device sectors . With an
expertise include: Indentifying emerging
developing insights from it. He has
studied medicine from Gujarat
in-depth understanding of primary
trends in life sciences industry,
worked on various consulting projects
University and also completed his MBA
research, he has conducted
Competitor landscape assessment,
across different geographies including
from IIM-Kozhikode. Purav started his
hundreds of interviews of various
Disease opportunity assessments etc.
Asia, Europe, US, MENA. He has been
career with Deloitte working on strategy
stakeholders in pharma & healthcare
She is a pro in secondary and primary
aligned in working for sector reports of
consulting engagements and also co-
& completed several research
research with a deep domain expertise
various geographies along with market
founded ConvergeHealth by Deloitte.
projects across life sciences industry.
in healthcare sector.
sizing and forecasting.
7 years of experience working with leading organizations in pharma, MedTech and healthcare domain. Some of our recent clients are mentioned below
… and many more
We would be happy to help.
Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
Reads:
14
Pages:
59
Published:
Jan 2024
Everything You Ever Wanted To Know About Infinite Banking
Formats: PDF, Epub, Kindle, TXT
Reads:
4
Pages:
61
Published:
Jan 2024
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. Th...
Formats: PDF, Epub, Kindle, TXT
Reads:
4
Pages:
27
Published:
Oct 2023
The global breast cancer therapeutics market is poised for substantial expansion, forecasted to increase from $18.2 Bn in 2022 to an impressive $48.0 Bn by 20...
Formats: PDF, Epub, Kindle, TXT
Reads:
21
Pages:
23
Published:
Sep 2023
Get ready to embark on a delightful trip down memory lane with \"Nostalgia\"! The pages of this captivating book will transport us back to the days of my high...
Formats: PDF, Epub, Kindle, TXT
